SCHEMBL17023101

SCHEMBL17023101

COc1cc(OC)c(Cl)c(-c2ccc(OC(=O)Nc3ccc(N4CCN(C(C)C)CC4)nc3)c3nccnc23)c1Cl

nearest known ligand 0.64

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 16/20 0.64
ALDH1A1 P00352 1/20 0.41
FGFR1 P11362 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17023023 0.90 FGFR3 (0.63) FGFR3FGFR1
SCHEMBL17023056 0.89 FGFR3 (0.79) FGFR3FGFR1
SCHEMBL1127090 0.89 FGFR3 (0.81) FGFR3
SCHEMBL17023160 0.89 FGFR3 (0.80) FGFR3
SCHEMBL17023105 0.85 FGFR3 (0.79) FGFR3
SCHEMBL17023154 0.80 FGFR3 (0.65) FGFR3FGFR1
SCHEMBL1126675 0.79 FGFR3 (0.80) FGFR3
SCHEMBL17023167 0.79 FGFR3 (0.69) FGFR3
SCHEMBL17023031 0.79 FGFR3 (0.65) FGFR3
SCHEMBL17023066 0.78 FGFR3 (0.78) FGFR3ALDH1A1FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-B1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2015-08-26 EP claimed